Showing 1 - 20 results of 43 for search 'Pierfrancesco Tassone', query time: 0.06s
Refine Results
-
1
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report by Maria Anna Siciliano, Stefano Dastoli, Stefano Dastoli, Maria d’Apolito, Nicoletta Staropoli, Pierfrancesco Tassone, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierosandro Tagliaferri, Vito Barbieri
Published 2020-10-01
Article -
2
-
3
-
4
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity by Nicoletta Staropoli, Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza, Martina Costa, Giacomo Rossini, Francesco Manti, Antonella Crispino, Caterina Riillo, Domenico Ciliberto, Mariamena Arbitrio, Pierfrancesco Tassone, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierosandro Tagliaferri
Published 2023-07-01
Article -
5
-
6
-
7
-
8
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives by Daniele Caracciolo, Antonia Mancuso, Nicoletta Polerà, Caterina Froio, Giuseppe D’Aquino, Caterina Riillo, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published 2023-01-01
Article -
9
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice by Serena Ascrizzi, Grazia Maria Arillotta, Katia Grillone, Giulio Caridà, Stefania Signorelli, Asad Ali, Caterina Romeo, Pierfrancesco Tassone, Pierosandro Tagliaferri
Published 2023-08-01
Article -
10
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy by Maria Teresa Di Martino, Caterina Riillo, Francesca Scionti, Katia Grillone, Nicoletta Polerà, Daniele Caracciolo, Mariamena Arbitrio, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published 2021-03-01
Article -
11
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes by Francesca Scionti, Giuseppe Agapito, Daniele Caracciolo, Caterina Riillo, Katia Grillone, Mario Cannataro, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone, Mariamena Arbitrio
Published 2022-01-01
Article -
12
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter” by Katia Grillone, Caterina Riillo, Francesca Scionti, Roberta Rocca, Giuseppe Tradigo, Pietro Hiram Guzzi, Stefano Alcaro, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published 2020-06-01
Article -
13
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis by Domenico Ciliberto, Giulio Caridà, Nicoletta Staropoli, Caterina Romeo, Grazia Maria Arillotta, Cristina Napoli, Luigia Gervasi, Francesco Luciano, Caterina Riillo, Pierfrancesco Tassone, Pierosandro Tagliaferri
Published 2023-08-01
Article -
14
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach by Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta, Pierpaolo Correale, Pierpaolo Correale
Published 2022-09-01
Article -
15
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma by Nicola Amodio, Maria Eugenia Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published 2019-02-01
Article -
16
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates by Maria Eugenia Gallo Cantafio, Boye Schnack Nielsen, Chiara Mignogna, Mariamena Arbitrio, Cirino Botta, Niels M Frandsen, Christian Rolfo, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Di Martino
Published 2016-01-01
Article -
17
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling by Maria Francesca Santolla, Rosamaria Lappano, Francesca Cirillo, Damiano Cosimo Rigiracciolo, Anna Sebastiani, Sergio Abonante, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Di Martino, Marcello Maggiolini, Adele Vivacqua
Published 2018-05-01
Article -
18
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells by Katia Todoerti, Maria Eugenia Gallo Cantafio, Manuela Oliverio, Giada Juli, Carmine Rocca, Rita Citraro, Pierfrancesco Tassone, Antonio Procopio, Giovambattista De Sarro, Antonino Neri, Giuseppe Viglietto, Nicola Amodio
Published 2021-10-01
Article -
19
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma by Giada Juli, Manuela Oliverio, Dina Bellizzi, Maria Eugenia Gallo Cantafio, Katia Grillone, Giuseppe Passarino, Carmela Colica, Monica Nardi, Marco Rossi, Antonio Procopio, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio
Published 2019-07-01
Article -
20
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma by Daniele Caracciolo, Caterina Riillo, Giada Juli, Francesca Scionti, Katia Todoerti, Nicoletta Polerà, Katia Grillone, Lucia Fiorillo, Mariamena Arbitrio, Maria Teresa Di Martino, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published 2021-08-01
Article